Clinical trial · Interventional
iCANSleep: Smartphone App-Based Insomnia Treatment for Cancer Survivors
iCANSleep: A Randomized Controlled Trial of a Smartphone App-Based Insomnia Treatment for Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators will answer the question of whether treating insomnia using the mobile-app-based intervention of Cognitive Behavioural Therapy for Insomnia (CBT-I) for cancer survivors ("iCANSleep") can improve symptoms of insomnia in Canadian cancer survivors compared to a waitlist control group. The investigators will recruit 146 people with insomnia who have completed cancer treatment at least 3 months prior to the study.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Insomnia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| App-Based Cognitive Behavioural Therapy for Insomnia | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Immediate Treatment
- description
- The immediate treatment group will begin the app-based insomnia intervention immediately after enrolling.
- interventionNames
- Behavioral: App-Based Cognitive Behavioural Therapy for Insomnia
- type
- EXPERIMENTAL
- label
- Waitlist Control
- description
- The waitlist control group will begin the app-based intervention after a waiting period of 8 weeks after enrolling.
- interventionNames
- Behavioral: App-Based Cognitive Behavioural Therapy for Insomnia
Primary outcomes (5)
- measure
- Insomnia Severity
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Cancer survivors * Over 18 years of age * Lives in Canada * Understands English or French fluently * DSM-5 diagnosis of insomnia * ISI score of 8 or higher * Good performance status as indicated by a score of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance status scale * Access to internet connection * Ownership of smartphone * Fluency using mobile applications. * Individuals with non-hematological malignancies must show no evidence of cancer or clinically stable/inactive disease for a minimum of 3 months prior to enrollment (for individuals with non-metastatic cancer) or be on a stable treatment regimen for the prior 3 months (for individuals with metastatic cancer) to ensure that insomnia is not a direct, acute response to cancer treatment. * Individuals with hematological malignancies must be in remission at the time of recruitment and have completed cancer treatments (e.g., transplant, chemotherapy, immunotherapy, radiotherapy) at least 3 months prior. Exclusion Criteria: * Presence of a sleep disorder other than insomnia that is not adequately treated (e.g., untreated sleep apnea) * Presence of a psychological disorder that is currently untreated or would impair the ability to participate (e.g., bipolar disorder) * Major sensory deficit (e.g., blindness) * Previous experience receiving CBT-I. * The use of medications prescribed for sleep (e.g., hypnotics, sedatives, or antidepressants) will be tracked and adjusted for in the statistical analysis.
References
Publications (0)
Data not yet available